OUT OF MIND
Would you like to react to this message? Create an account in a few clicks or log in to continue.
Latest topics
» Ultra-Fast Comet Leonard is Coming - Now's the Time to Start Tracking the Comet at Dawn
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 1:56 pm by PurpleSkyz

» Could we detect alien probes that are inside our own solar system ?
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 1:54 pm by PurpleSkyz

» James Comey’s daughter is a lead prosecutor in Ghislaine Maxwell’s child sex trafficking case. Here’s what we know about her
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 1:49 pm by PurpleSkyz

» ‘Sky Gods’, Credo Mutwa & The Alien Agenda
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 1:45 pm by PurpleSkyz

» USGS: Magnitude-7.5 earthquake strikes northern Peru
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 1:35 pm by PurpleSkyz

» Ten OMICRON “variant” predictions for 2022 and beyond
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 1:11 pm by PurpleSkyz

» Ancient Secret Societies, UFOs, and the New World Order
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 1:06 pm by PurpleSkyz

» The Van Allen Belts
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 1:02 pm by PurpleSkyz

» Report: World’s First Vaccine Murder Case Against Bill Gates Filed In India’s High Court
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 12:55 pm by PurpleSkyz

» New York physician assistant says she was told to stop reporting COVID shot injuries
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 12:52 pm by PurpleSkyz

» “Australia Needs Lions Not Sheep”: Melbourne Streets Overflow as Protestors Stand for Freedom
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 12:49 pm by PurpleSkyz

» The Spanish Basque Court Revolts and Suspends the Health Pass for Violation of Rights
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 12:46 pm by PurpleSkyz

» Media Says Rise in Football Players Suddenly Collapsing is a “Coincidence”
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 12:41 pm by PurpleSkyz

» OMICRON: A Perfectly Timed Variant to Scare the Unruly Back into Submission
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 12:20 pm by PurpleSkyz

» Solutions for Healing from the mRNA Bioweapon
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 12:15 pm by PurpleSkyz

» EUDRA Adverse Reaction Stats Through November 20th, 2021
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyToday at 12:08 pm by PurpleSkyz

» Report: Newly Released Records Reveal What Really Happened in Epstein’s Final Moments
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyYesterday at 11:19 am by PurpleSkyz

» Huge Freedom Protests Again Bring Australian Cities to a Standstill
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyYesterday at 10:57 am by PurpleSkyz

» Big Pharma Unveils Its Plans For Omicron Strain
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyYesterday at 10:45 am by PurpleSkyz

» ‘Planet Ponzi’, The Magic Money Tree of Modern Monetary Theory
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyYesterday at 10:42 am by PurpleSkyz

» 301 new extra-solar planets to Kepler’s total count
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyYesterday at 10:33 am by PurpleSkyz

» Scientists Create Genetically Modified E Coli Bacteria for 3D Ink Printing
Trial of COVID-19 blood plasma finds no benefit in severely ill patients EmptyYesterday at 10:30 am by PurpleSkyz





Holistic Alternative
Health Care
by Bridgette Lyn Dolgoff

CONTACT HERE TO SCHEDULE ONLINE SESSIONS
www.https://coe-llc.com

NEW ETSY SHOP FEATURING HERBAL SALVES

NOW MAKING A MEDICATED OIL FOR PEOPLE WHO HAVE PCR DAMAGE
www.https://coe-llc.com










Sway on Out Of Mind:
Sway's Website:
josuemercadoproductions.tk
Buy Me A Coffee:
PayPal:www.paypal.me/swaymerk CashApp:

You are not connected. Please login or register

OUT OF MIND » BREAKING NEWS & HOT TOPICS » COVID-19 » Trial of COVID-19 blood plasma finds no benefit in severely ill patients

Trial of COVID-19 blood plasma finds no benefit in severely ill patients

Go down  Message [Page 1 of 1]

PurpleSkyz

PurpleSkyz
Admin

Trial of COVID-19 blood plasma finds no benefit in severely ill patients

By Kate Kelland

Trial of COVID-19 blood plasma finds no benefit in severely ill patients C11bac89e29afe2deba0b5da36760297

LONDON (Reuters) - An international trial testing convalescent blood plasma on COVID-19 patients with moderate and severe illness has halted enrolment of severely ill COVID-19 patients requiring intensive care after it found no benefit, trial investigators said on Monday.

FILE PHOTO: Blood collection specialist Kathryn Severson holds a bag of convalescent plasma from a recovered coronavirus patient at the Central Seattle Donor Center of Bloodworks Northwest during the coronavirus disease (COVID-19) global outbreak, in Seattle, Washington, U.S. September 2, 2020. REUTERS/Lindsey Wasson

The decision by the REMAP-CAP trial leaders came after an initial analysis of more than 900 severely ill trial participants in intensive care showed that treatment with the product - an antibody-rich plasma taken from people who have recovered from the pandemic disease - did not improve outcomes.
“There was no evidence of harm associated with the administration of convalescent plasma” (and) the trial is continuing to recruit hospitalised COVID-19 patients who are moderately ill but not in intensive care, scientists leading the trial said in a statement.
“It is biologically plausible that patients who are not producing antibodies at the time of convalescent plasma therapy and those patients with excess virus may benefit more than others. Our additional analyses will explore this,” said Manu Shankar-Hari, a clinician and professor of critical care medicine at Britain’s Guy’s and St Thomas’ hospital, who is co-leading the trial.
Advertisement
He added that the initial analysis did not assess plasma’s effects in hospitalised patients with less severe disease. This “remains a very important question” and would continue to be explored in the ongoing trial, he said.
The underlying hypothesis for using convalescent plasma as a potential treatment for COVID-19 patients is that the antibodies it contains could neutralize the virus, stopping it from replicating and halting tissue damage.
But this initial analysis leading to the REMAP-CAP pause in enrolment of critically ill patients showed there was a very low probability - 2.2% - that it reduced death rates or decreased the number of days patients needed intensive care.
Advertisement
“Why convalescent plasma does not seem to improve outcome in severely ill COVID-19 patients admitted to the ICU is not yet known. However, it may be because the lung damage is too advanced for convalescent plasma to make a difference,” said Alexis Turgeon, a critical care doctor and professor at Université Laval in Canada, who is also working on the trial.
REMAP-CAP is an international clinical trial exploring potential treatments for COVID-19. It has already recruited 4,100 COVID-19 patients at more than 290 clinical sites across Europe, the Americas, Asia, Africa and Australasia.
Separate findings from REMAP-CAP showed last week that treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improved survival rates and reduced the amount of time patients need intensive care.
The trial is also looking at potential effects of a range of other existing therapies, including anticoagulation medicines, antiplatelet agents, antibiotics, statins and vitamin C.
Reporting by Kate Kelland; Editing by Nick Macfie

https://www.reuters.com/article/us-health-coronavirus-plasma-idUSKBN29G1JZ/

Thanks to: https://www.reuters.com



  

Back to top  Message [Page 1 of 1]

Permissions in this forum:
You cannot reply to topics in this forum